CBD Life Sciences Inc.
CBDL
$0.0004
$0.000.00%
| 03/31/2024 | 03/31/2023 | 03/31/2022 | 12/31/2021 | 09/30/2021 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 100.00 | 600.00 | 1.03M | 1.03M | 1.03M |
| Total Receivables | 176.00K | -- | -- | -- | -- |
| Inventory | 9.20K | -- | -- | 46.10K | 46.10K |
| Prepaid Expenses | -- | -- | -- | -- | -- |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 185.30K | -- | -- | 1.07M | 1.07M |
|
|
|||||
| Total Current Assets | 185.30K | -- | -- | 1.07M | 1.07M |
| Net Property, Plant & Equipment | 74.50K | -- | -- | 185.80K | 185.80K |
| Long-term Investments | 100.00K | -- | -- | 100.00K | 100.00K |
| Goodwill | 100.00K | -- | -- | 100.00K | 100.00K |
| Total Other Intangibles | 22.10K | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 4.90K | -- | -- | 4.90K | 4.90K |
| Total Assets | 386.70K | -- | -- | 1.36M | 1.36M |
|
|
|||||
| Total Accounts Payable | -- | -- | -- | -- | -- |
| Total Accrued Expenses | 20.00K | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Liabilities | 24.60K | -- | -- | -- | -- |
| Total Other Current Liabilities | 24.60K | -- | -- | -- | -- |
| Total Current Liabilities | 44.50K | -- | -- | -- | -- |
|
|
|||||
| Total Current Liabilities | 44.50K | -- | -- | -- | -- |
| Long-Term Debt | -- | -- | -- | -- | -- |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | 30.40K | 30.40K |
| Total Liabilities | 44.50K | -- | -- | 30.40K | 30.40K |
|
|
|||||
| Common Stock & APIC | 14.89M | -- | -- | 14.89M | 14.89M |
| Retained Earnings | -14.61M | -- | -- | -13.62M | -13.62M |
| Treasury Stock & Other | -- | -- | -- | -- | -- |
| Total Common Equity | 276.10K | 68.40K | 1.27M | 1.27M | 1.27M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | 66.10K | -- | -- | 66.10K | 66.10K |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | 66.10K | 66.10K | 66.10K | 66.10K | 66.10K |
|
|
|||||
| Total Common Equity | 276.10K | 68.40K | 1.27M | 1.27M | 1.27M |
| Total Preferred Equity | 66.10K | 66.10K | 66.10K | 66.10K | 66.10K |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | 342.20K | 134.50K | 1.33M | 1.33M | 1.33M |
|
|
|||||
